Ahn Receives Mayer Mitchell Award for Excellence in Cancer 研究
2017年12月13日发布
移动癌症研究员. 艾琳·安恩英 has been named the recipient of the 2017 Mayer Mitchell Award for Excellence in Cancer 研究.
的 award, announced December 7, 2017, is presented annually to a promising scientist at 美国米切尔癌症研究所 根据教务委员会的推荐. 其中包括1万美元的奖金. 的 award was established in 2009 by USA Trustee Arlene Mitchell in memory of her late husband, Mayer Mitchell, a Mobile businessman, longtime USA trustee and formative 在MCI的建立中起了重要作用.
Ahn, an associate professor of oncologic sciences at MCI, focuses her research on the regulation of gene expression in cancer development and progression, with a special 对白血病的兴趣. 2015年,她获得了5年1美元的奖金.700万R01拨款 from the National Cancer Institute to study the role of the SON protein in the development 的白血病.
"Dr. Ahn discovered that the SON gene controls the behavior of the genetic material in cells and that the SON protein enables the formation 的白血病s and brain tumors. Her work may provide a pathway for new classes of treatment for these cancers," said Dr. Arthur "Art" Frankel, interim associate director of Basic and Translational Sciences.
Ahn joined MCI in 2012 after working as an assistant project scientist at the Moores Cancer Center at the University of California, San Diego. 她获得了博士学位.D. in Molecular and Cellular Pathology from the University of Alabama at Birmingham and postdoctoral training at the Scripps 研究 Institute and Moores Cancer Center.
Upon receiving the award Thursday, Ahn spoke directly to young researchers in the 人群. "Think about what you want to achieve after many years, and have a big dream," 她说.
Ahn is the recipient of numerous professional awards, including international awards for research in leukemia and allied conditions from Lady TATA Memorial Trust, United 王国. Her research on the SON gene has been published in the prestigious journal 分子细胞.